Scientific Overview: AKT inhibitor; combined with carfilzomib in multiple myeloma. AKT + proteasome inhibitor combination
Mechanism of Action: Pan-AKT Inhibitor
Purity: ≥99% | Molecular Formula: C21H25ClN4O3S
For Research Use Only. Not intended for diagnostic, therapeutic, or clinical applications.